Suchergebnisse - "Bevan, Charlotte L"

PubPharm (90)

1

The antiviral potential of the antiandrogen enzalutamide and the viral-androgen signaling interplay in seasonal coronaviruses

enthalten in: Journal of medical virology | 2024

von Abdullahi, T. | Somji, R. | Bevan, C. | +4

2

Correction : The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

enthalten in: British journal of cancer | 2024

von Constantin, T. | Varela-Carver, A. | Greenland, K. | +13

ErratumFor: Br J Cancer. 2023 Jun;128(12):2326-2337. - PMID 37076563

3

The antiviral potential of the antiandrogen enzalutamide and the viral‐androgen signaling interplay in seasonal coronaviruses

enthalten in: Journal of Medical Virology | 2024

von Ogunjinmi, O. | Abdullahi, T. | Somji, R. | +5

4

The antiviral potential of the antiandrogen enzalutamide and the viral-androgen interplay in seasonal coronaviruses

enthalten in: bioRxiv.org | 2023

von Ogunjinmi, O. | Abdullahi, T. | Somji, R. | +5

5

Handheld ISFET Lab-on-Chip detection of TMPRSS2-ERG and AR mRNA for prostate cancer prognostics

enthalten in: IEEE sensors letters | 2023

von Broomfield, J. | Kalofonou, M. | Franklin, S. | +5

6

The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

enthalten in: British journal of cancer | 2023

von Constantin, T. | Varela-Carver, A. | Greenland, K. | +13

ErratumIn: Br J Cancer. 2024 Feb 14;:. - PMID 38355841

7

AMPK activation protects against prostate cancer by inducing a catabolic cellular state

enthalten in: Cell reports | 2023

von Penfold, L. | Woods, A. | Pollard, A. | +15

8

Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy

enthalten in: Cancers | 2022

von Buxton, A. | Abbasova, S. | Bevan, C. | +1

9

Detection of YAP1 and AR-V7 mRNA for Prostate Cancer Prognosis Using an ISFET Lab-On-Chip Platform

enthalten in: ACS sensors | 2022

von Broomfield, J. | Kalofonou, M. | Pataillot-Meakin, T. | +5

10

Genome-wide analyses of transcription factors and co-regulators across seven cohorts identified reduced PPARGC1A expression as a driver of prostate cancer progression

enthalten in: bioRxiv.org | 2022

von Siddappa, M. | Wani, S. | Long, M. | +4

1
2
3
4
5
6
7
8
9
Nächster »
[9]